NCT00274547 - Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

1,829

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

February 28, 2003

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium

Trial Locations (26)

Boehringer Ingelheim Investigational Site, Birmingham

Carl T. Hayden VA Medical Center, Phoenix

Southern Arizona VA Health Care System, Tuscon

VA Long Beach Healthcare System, Long Beach

Boehringer Ingelheim Investigational Site, Palo Alto

Respiratory Diseases (111A), Bay Pines

J. Hillis Miller Health Center, Gainesville

Veteran Affairs Medical Center, Hines

Veterans Affairs Medical Center, North Chicago

Boehringer Ingelheim Investigational Site, Indianapolis

Boehringer Ingelheim Investigational Site, Lexington

4720 I-10 Service Road, Metairie

Boehringer Ingelheim Investigational Site, Boston

Veteran Affairs Medical Center, Minneapolis

Boehringer Ingelheim Investigational Site, Kansas City

Boehringer Ingelheim Investigational Site, Omaha

Boehringer Ingelheim Investigational Site, Reno

Boehringer Ingelheim Investigational Site, Buffalo

Bronx VA Medical Center, New York

Boehringer Ingelheim Investigational Site, Durham

Dallas VAMC, Dallas

Veterans Affairs Medical Center, Houston

Boehringer Ingelheim Investigational Site, San Antonio

Boehringer Ingelheim Investigational Site, Salt Lake City

Hampton VA Medical Center, Hampton

Hunter Holmes McGuire Medical Center, Richmond